Dow Up 0.03% Nasdaq Up 0.33%

NPS Pharmaceuticals, Inc. (NPSP)

-NasdaqGS
29.12 Down 1.06(3.51%) 10:56AM EDT - Nasdaq Real Time Price
Prev Close:30.18
Open:30.18
Bid:29.16 x 200
Ask:29.19 x 200
1y Target Est:37.46
Beta:0.08
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:29.00 - 30.23
52wk Range:21.60 - 39.68
Volume:656,474
Avg Vol (3m):1,959,310
Market Cap:3.10B
P/E (ttm):N/A
EPS (ttm):-0.12
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
NPSPDown 3.51%3.10B
ABTDown 0.09%63.46B
BIIBUp 0.06%81.05B

Key Statistics

Forward P/E (1 yr):25.36
P/S (ttm):16.59
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.03
Quarterly EPS Est (Sep-14) :0.01
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):9.25

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

NPS Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapeutic products in the United States. Its lead product is Gattex for the treatment of adult patients with short bowel syndrome (SBS) who are dependent on pa... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback